Role of the Presenilin1mediated Cleavage of E-cadherin

Principal Investigator
Philippe Marambaud, PhD
Icahn School of Medicine at Mount Sinai
New York, NY, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
April 01, 2002 - March 31, 2004
Grant ID
A2002061
Summary
Mutations in presenilin-1 (PS1) are responsible for familial Alzheimer’s disease (FAD), also known as early-onset Alzheimer’s disease. PS1 is found at the plasma membrane and is involved in cell-cell contacts. It interacts with E-cadherin, a cell surface molecule that facilitates cell-cell adhesions and has a crucial role in the structure of the synapse, the region involved in neuron communication. E-cadherin forms complexes with cytosolic proteins, like catenins, to link the actin cytoskeleton. The remodeling of cell-cell interactions is a central determinant for many functions, including tissue repair, cell migration and cell death. The molecular mechanisms involved in the disassembly of cell-cell associations are not clearly understood. It has been shown E-cadherin processing is mediated by PS1/gamma secretase activity. Dr. Marambaude is investigating whether PS1-mediated cleavage of E-cadherin disconnects the cadherin with the cytoskeleton and plays a role in the disassembly of cell-cell adhesions. He also plans to study the signaling pathways that are activated by the PS1/gamma secretase-mediated processing of E-cadherin and the subsequent disassembly of cadherin/catenin complexes. Finally, he will examine whether mutated PS1 in FAD abnormally affects its activity to cleave E-cadherin and thereby participating in the neuronal loss observed in Alzheimer’s disease. This project will help to determine the usefulness of treatments using gamma-secretase inhibitors in altering the E-cadherin-dependent adhesion and signaling systems.
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Current Organization
Douglas Research Centre
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Current Organization
Douglas Research Centre